870281-85-9

基本信息
IDELALISIB N-2中間體
CAL101 IDELALISIB N-2中間體
CAL-101(N-2)IDELALISIB N-2中間體
二氫-4-氧代-3-苯基-2-喹唑啉基)丙基]氨基甲酸叔丁酯
CAL-101(N-2)IDELALISIB N-2中間體 250G
(S)-(1-(5-氟-4-氧代-3-苯基-3,4-二氫喹唑啉-2-基)丙基)氨基甲酸叔丁酯
[(1S)-1-(5-氟-3,4-二氫-4-氧代-3-苯基-2-喹唑啉基)丙基]氨基甲酸叔丁酯
[(1S)-1-(5-氟-3, 4-二氫-4-氧代-3-苯基-2-喹唑啉YL) 丙基]-氨基甲酸1, 1-二甲基乙酯
tert-butyl (S)-[1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl]carbamate
(S)-tert-butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbaMate
(S)-tert-butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbaMate(CAL101 N-2 step)
[(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester
(S)-tert-butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbaMate, [(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester
制備方法

870281-84-8

870281-85-9
3. 制備(S)-[1-(5-氟-4-氧代-3-苯基-3,4-二氫喹唑啉-2-基)丙基]氨基甲酸叔丁酯 在200 mL反應(yīng)燒瓶中,將化合物(V)(8.9 g,0.02 mol)溶于100 mL乙酸中,攪拌至完全溶解。向反應(yīng)體系中分批加入鋅粉(9.1 g,0.14 mol),控制反應(yīng)溫度為25°C,持續(xù)攪拌3小時(shí)。反應(yīng)完成后,通過真空過濾收集反應(yīng)混合物,并用乙酸(50 mL)洗滌濾餅。將濾液濃縮,濾餅用二氯甲烷(100 mL)和水(50 mL)洗滌。隨后,用二氯甲烷(50 mL)萃取水層,合并有機(jī)相,依次用飽和碳酸鈉溶液(50 mL)和飽和鹽水(50 mL)洗滌。有機(jī)層用無(wú)水硫酸鎂干燥,濃縮后得到白色固體化合物(VI),即(S)-[1-(5-氟-4-氧代-3-苯基-3,4-二氫喹唑啉-2-基)丙基]氨基甲酸叔丁酯(6.2 g),產(chǎn)率為78%,純度為95%。
參考文獻(xiàn):
[1] Patent: CN104130261, 2016, B. Location in patent: Paragraph 0055; 0056; 0057; 0058
[2] Patent: WO2005/113554, 2005, A2. Location in patent: Page/Page column 24-25; 27-28
[3] Organic Preparations and Procedures International, 2016, vol. 48, # 4, p. 337 - 341
[4] Patent: WO2016/108206, 2016, A2. Location in patent: Page/Page column 47; 48
[5] RSC Advances, 2018, vol. 8, # 28, p. 15863 - 15869